Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
TeraImmune, Inc.
*MAILING ADDRESS
704 Quince Orchard Rd. Suite 160
*CITY
Gaithersburg
*STATE
(Required for U.S. applicants)
Maryland
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
20878
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceutical preparations for the treatment of autoimmune diseases and conditions; pharmaceutical preparations for the treatment of
hemophilia; pharmaceutical preparations for the treatment of cancer and tumors; pharmaceutical preparations for the treatment of multiple sclerosis, atopic dermatitis, anti-drug antibody formation
and xenotransplantation; pharmaceutical preparations for use in immunotherapy, namely, regulatory t-cell therapy.
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
040
*IDENTIFICATION
Manufacturing services for pharmaceutical products; providing technical information in the field of pharmaceutical manufacturing; custom
manufacturing of pharmaceuticals.
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
042
*IDENTIFICATION
Medical and pharmaceutical research and development services; scientific research and development services in the medical field; providing
medical and scientific information in the medical field; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information relating to
diagnostic, prophylactic and therapeutic properties of pharmaceuticals; scientific research and development services in the field of regulatory t-cell and chimeric antigen receptor therapy;
scientific research and development services in the field of new cancer therapies; medical and veterinary research services, namely, the manipulation of cells within a laboratory or research facility
to enable the cells to be used for therapeutic purposes; scientific research in human and animal gene therapy; scientific research into vectors and preparations for manipulating and adapting human
and animal cells; consultancy relating to all the aforesaid services.
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
044
*IDENTIFICATION
Providing medical information in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis,
atopic dermatitis, anti-drug antibody formation and xenotransplantation; providing a website featuring information in the medical field and in the field of pharmaceuticals, autoimmune diseases and
conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; consulting in the field of pharmaceuticals, autoimmune diseases and
conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; medical services; veterinary services; medical services in the extraction
of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients for medical purposes; providing medical
and therapy advice and consultancy in the field of medical and veterinary therapies; providing cancer therapy advice and consultancy.
FILING BASIS
SECTION 1(b)
ATTORNEY INFORMATION
NAME
Harold Milstein
ATTORNEY DOCKET NUMBER
74TV-321544
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Sheppard Mullin Richter & Hampton LLP
STREET
379 Lytton Avenue
CITY
Palo Alto
STATE
California
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
94301
PHONE
650-815-2600
FAX
650-815-2601
EMAIL ADDRESS
svtmdocketing@sheppardmullin.com
OTHER APPOINTED ATTORNEY
Chelseaa Bush and the firm
CORRESPONDENCE INFORMATION
NAME
Harold Milstein
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
svtmdocketing@sheppardmullin.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
4
APPLICATION FOR REGISTRATION PER CLASS
275
*TOTAL FEES DUE
1100
*TOTAL FEES PAID
1100
SIGNATURE INFORMATION
SIGNATURE
/ChelseaaBush/
SIGNATORY'S NAME
Chelseaa Bush
SIGNATORY'S POSITION
Attorney of Record, California bar member
SIGNATORY'S PHONE NUMBER
650-815-2600
DATE SIGNED
09/11/2020
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:90175258
Filing Date:09/11/2020
To the Commissioner for Trademarks:
MARK: TREGING (Standard Characters, see mark)
The literal element of the mark consists of TREGING. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, TeraImmune, Inc., a corporation of Delaware, having an address of
704 Quince Orchard Rd. Suite 160
Gaithersburg, Maryland 20878
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Pharmaceutical preparations for the treatment of autoimmune diseases and conditions; pharmaceutical preparations for the treatment of hemophilia; pharmaceutical
preparations for the treatment of cancer and tumors; pharmaceutical preparations for the treatment of multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation;
pharmaceutical preparations for use in immunotherapy, namely, regulatory t-cell therapy.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 040: Manufacturing services for pharmaceutical products; providing technical information in the field of pharmaceutical manufacturing; custom manufacturing of
pharmaceuticals.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 042: Medical and pharmaceutical research and development services; scientific research and development services in the medical field; providing medical and scientific
information in the medical field; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information relating to diagnostic, prophylactic
and therapeutic properties of pharmaceuticals; scientific research and development services in the field of regulatory t-cell and chimeric antigen receptor therapy; scientific research and
development services in the field of new cancer therapies; medical and veterinary research services, namely, the manipulation of cells within a laboratory or research facility to enable the cells to
be used for therapeutic purposes; scientific research in human and animal gene therapy; scientific research into vectors and preparations for manipulating and adapting human and animal cells;
consultancy relating to all the aforesaid services.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 044: Providing medical information in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug
antibody formation and xenotransplantation; providing a website featuring information in the medical field and in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer,
multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; consulting in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer,
multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; medical services; veterinary services; medical services in the extraction of human and animal cells from
patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients for medical purposes; providing medical and therapy advice and
consultancy in the field of medical and veterinary therapies; providing cancer therapy advice and consultancy.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The owner's/holder's proposed attorney information: Harold Milstein. Other appointed attorneys are Chelseaa Bush and the firm. Harold Milstein of Sheppard Mullin Richter & Hampton LLP, is a
member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
379 Lytton Avenue
Palo Alto, California 94301
United States
650-815-2600(phone)
650-815-2601(fax)
svtmdocketing@sheppardmullin.com
The docket/reference number is 74TV-321544.
Harold Milstein submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Harold Milstein
PRIMARY EMAIL FOR CORRESPONDENCE: svtmdocketing@sheppardmullin.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT
PROVIDED
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1100 has been submitted with the application, representing payment for 4 class(es).
Declaration
Declaration Signature
Signature: /ChelseaaBush/ Date: 09/11/2020
Signatory's Name: Chelseaa Bush
Signatory's Position: Attorney of Record, California bar member
Payment Sale Number: 90175258
Payment Accounting Date: 09/11/2020
Serial Number: 90175258
Internet Transmission Date: Fri Sep 11 17:40:15 ET 2020
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.X-20200911174015399
022-90175258-750ef9fe2051ad5c495dd1ef52d
478864544841b9117849822c186ab8ce8f38eec-
DA-40150557-20200911172648531013